Second Opinion October 24, 2024
Christina Farr

I’m introducing a new series to ask experts in the space tough questions about topics of the moment

At Second Opinion, we like to get creative and try new things. So, one series I’ve been thinking about for a while is “4 Questions With.” It’s exactly what you’d think. It’s a set of questions to an expert on a topic we’re all wondering about and tracking in health tech.

What this series is not:

  • An interview with someone talking about why they’re so great or a sub-sector is so hot;

  • A bunch of predictions or opinions (if you want to contribute that, consider reaching out about a column instead);

  • ...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Interview / Q&A, Pharma, Pharma / Biotech, Trends
Navigating CMC insights for success in drug development
Novartis pays $1bn upfront for Huntington's drug from PTC
The Real Reasons Drug Prices Are So High
Pharma Pulse 12/2/24: Retooling the ‘Gene’ Value Machine & more
Roche Inks Deal to Acquire Poseida Therapeutics

Share This Article